News

INCATE to select ARIVA Med

The INCATE Selection Committee selected the Epimutilins program of ARIVA Med for STAGE I funding.

August 2024

INCATE

ARIVA Med at ESCMID-ASM 2024

Susanne Paukner presented the Epimutilins program (Abstract EA042) and the AR-2126 program (Abstract EA043) at the ESCMID-ASM in Porto, Portugal.


                                      September 2024

Poster AR-2126, in vitro activity & in vivo PoE after inhalation

Neuer Text

Oral presentation Epimutilins

AMR Conference in Basel, Switzerland, February 2025

The ARIVA Med team attended the AMR conference and pre-conference workshops and enjoyed networking with organizers and attendees

February 2025

ARIVA Med at the ESCMID Global 2025 in Vienna, Austria

The ARIVA Med team presented three posters (two selected for eFlash presentation) at the ESCMID Global


11-15 April 2025

Poster - In vivo PoE of AR-2126 in a carbapenem-resistant P. aeruginosa lung infection model

Neuer Text

Poster - In vitro activity and in vivo PoE of Epimutilins

Neuer Text

Poster - Epimutilins against MDR Mycobacterium tuberculosis